ResearchSafe

Boldenone Undecylenate (Boldenone Undecylenate (Equipoise / EQ))

Category: Anabolic Steroids. Status: Veterinary drug (controlled substance).

A long-acting anabolic steroid originally developed for veterinary use (Equipoise), valued for slow, steady lean gains and increased appetite and red blood cell production. Educational reference only.

How it works

Boldenone is a testosterone derivative with a double bond at the 1,2 position, giving moderate anabolic activity and low estrogen conversion. It stimulates erythropoiesis and appetite while binding androgen receptors.

Key facts

  • Molecular weight: 452.7 Da
  • Half-life: ~14 days
  • Bioavailability: Intramuscular injection
  • Storage: Room temperature; protect from light.

Dosing overview

  • Typical dose: Long cycles due to slow ester
  • Frequency: Weekly
  • Duration: Extended cycles (non-medical)
  • Route: Intramuscular injection

Protocol notes

  • The very long undecylenate ester requires extended cycles to see full effect.
  • Known for gradual quality gains and marked increases in red blood cells.
  • Appetite stimulation is commonly reported.

Reported benefits

  • Slow, steady lean gains
  • Increased red blood cell count
  • Appetite stimulation
  • Low estrogen conversion
  • Improved endurance (perceived)

Possible side effects

  • Very high hematocrit (clot risk)
  • Testosterone suppression
  • Long detection window
  • Androgenic effects
  • Mild estrogenic effects

Research

  • Boldenone anabolic profile (2015): Demonstrated anabolic and erythropoietic effects with low estrogenic activity in animal studies.

Compare Boldenone Undecylenate

Research and educational reference only. Not medical advice.